4925-88-6

Usage

Uses

Used in Pharmaceutical Industry:
2,5-Dimethoxy-4-methylbenzaldehyde is used as a key intermediate in the synthesis of various phenylamine derivatives, which have potential applications as psychotomimetics. These psychotomimetic compounds are of interest in the pharmaceutical industry due to their ability to mimic the effects of certain psychoactive substances, making them valuable for research and development of new medications for the treatment of various psychiatric disorders.
Used in Chemical Synthesis:
In addition to its pharmaceutical applications, 2,5-dimethoxy-4-methylbenzaldehyde is also utilized as a starting material in the synthesis of other organic compounds. Its unique chemical structure allows for a wide range of reactions, making it a versatile building block for the creation of various molecules with diverse properties and applications.
Used in Flavor and Fragrance Industry:
Due to its distinct aromatic properties, 2,5-dimethoxy-4-methylbenzaldehyde can also be used in the flavor and fragrance industry. It can be employed as a component in the formulation of various scents and flavors, adding depth and complexity to the final product.

InChI:InChI=1/C10H12O3/c1-7-4-10(13-3)8(6-11)5-9(7)12-2/h4-6H,1-3H3

Synthetic route

2,5-dimethoxy toluene (24599-58-4) + N-methyl-N-phenylformamide (93-61-8) → 2,5-dimethoxy-4-methylbenzaldehyde (4925-88-6)

Conditions	Yield
Stage #1: N-methyl-N-phenylformamide With trichlorophosphate at 20℃; for 0.833333h; Inert atmosphere; Stage #2: 2,5-dimethoxy toluene at 70℃; for 1h; Inert atmosphere;	86%
Stage #1: N-methyl-N-phenylformamide With trichlorophosphate at 20℃; for 0.666667h; Stage #2: 2,5-dimethoxy toluene at 50℃; for 6h; Stage #3: With sodium acetate; sodium hydrogensulfite more than 3 stages;	67%
(i) POCl3, (ii) /BRN= 2045336/; Multistep reaction;
With trichlorophosphate at 0 - 80℃; for 1h;
Stage #1: N-methyl-N-phenylformamide With trichlorophosphate at 20℃; for 4h; Stage #2: 2,5-dimethoxy toluene at 70℃; for 2h;

2,5-dimethoxy toluene (24599-58-4) + N,N-dimethyl-formamide (68-12-2, 33513-42-7) → 2,5-dimethoxy-4-methylbenzaldehyde (4925-88-6)

Conditions	Yield
With trichlorophosphate at 80℃; for 8h;	85.9%
With trichlorophosphate In 1,2-dichloro-ethane at 80℃; for 12h; Vilsmeier-Haack formylation;	80%
With trichlorophosphate at 60℃; for 24h; Formylation;

2,5-dihydroxy-4-methylbenzaldehyde (52010-89-6) + methyl iodide (74-88-4) → 2,5-dimethoxy-4-methylbenzaldehyde (4925-88-6)

Conditions	Yield
With potassium carbonate In acetone at 20℃; for 18h;	80%
With potassium carbonate In acetone at 25℃; for 20h;

2-(2,5-dimethoxy-4-methyl-phenyl)-[1,3]dioxolane (246543-82-8) → 2,5-dimethoxy-4-methylbenzaldehyde (4925-88-6) + 2-[1,3]dioxolan-2-yl-5-methyl-[1,4]benzoquinone

Conditions	Yield
With cobalt (III) fluoride In acetonitrile at 20℃; for 0.416667h; Oxidation; Demethylation;	A 20% B 55%

Dichloromethyl methyl ether (4885-02-3) + 2,5-dimethoxy toluene (24599-58-4) → 2,5-dimethoxy-4-methylbenzaldehyde (4925-88-6)

Conditions	Yield
With tin(IV) chloride 1.) CH2Cl2, 0 deg C, 1 h, 2.) CH2Cl2, a) 0 deg C, 30 min, b) RT, 1 h; Yield given. Multistep reaction;
Stage #1: 2,5-dimethoxy toluene With titanium tetrachloride In dichloromethane at 20℃; for 2h; Inert atmosphere; Cooling with ice; Stage #2: Dichloromethyl methyl ether In dichloromethane at 20℃; for 2.5h; Inert atmosphere; Cooling with ice;	9.1 g

2,5-dimethoxy toluene (24599-58-4) + dicyanozinc (557-21-1) → 2,5-dimethoxy-4-methylbenzaldehyde (4925-88-6)

Conditions	Yield
With hydrogenchloride; aluminium trichloride; sulfuric acid 1) tetrachloroethane, 8 h, 65-70 deg C 2) overnight, room temperature 3) steam distillation; Yield given. Multistep reaction;

2,5-dimethoxy-4-methylphenylmethanol (32176-96-8) → 2,5-dimethoxy-4-methylbenzaldehyde (4925-88-6)

Conditions	Yield
With selenium(IV) oxide

2-methylbenzene-1,4-diol (95-71-6) → 2,5-dimethoxy-4-methylbenzaldehyde (4925-88-6)

Conditions	Yield
Multi-step reaction with 2 steps 1: 82 percent / potassium hydroxide / methanol / 8 h / steam distillation 2: 1) HCl, aluminium chloride 2) aqueous H2SO4 / 1) tetrachloroethane, 8 h, 65-70 deg C 2) overnight, room temperature 3) steam distillation View Scheme

phosphorous oxychloride (POCl3) + 2,5-dimethoxy toluene (24599-58-4) + N-methyl-N-phenylformamide (93-61-8) → 2,5-dimethoxy-4-methylbenzaldehyde (4925-88-6)

Conditions	Yield
In water

2,5-dimethoxy-4-methylbenzaldehyde (4925-88-6) → 2-hydroxy-4-methyl-5-methoxybenzaldehyde (74516-54-4)

Conditions	Yield
With aluminium trichloride; sodium iodide In acetonitrile for 2h; Heating;	99%
With boron trichloride In dichloromethane at -78 - 20℃;	65%
Stage #1: 2,5-dimethoxy-4-methylbenzaldehyde With aluminum (III) chloride; sodium iodide In acetonitrile at 80℃; for 1h; Stage #2: With water In acetonitrile at 0℃;

2,5-dimethoxy-4-methylbenzaldehyde (4925-88-6) → 2,5-dihydroxy-4-methylbenzaldehyde (52010-89-6)

Conditions	Yield
With boron tribromide In dichloromethane at -78℃; for 8h;	99%
With boron tribromide In dichloromethane at -78℃; for 24h;	87%

2,5-dimethoxy-4-methylbenzaldehyde (4925-88-6) → 2,5-dimethoxy-4-methylphenol

Conditions	Yield
Stage #1: 2,5-dimethoxy-4-methylbenzaldehyde With sodium hydrogencarbonate; 3-chloro-benzenecarboperoxoic acid In dichloromethane at -10℃; for 1h; Inert atmosphere; Stage #2: With potassium hydroxide In methanol at 20℃; for 0.5h; Inert atmosphere;	98%

2,5-dimethoxy-4-methylbenzaldehyde (4925-88-6) → C10H13NO3 (32230-29-8)

Conditions	Yield
With hydroxylamine hydrochloride; sodium acetate In methanol at 20℃; for 18h;	92%
With hydroxylamine hydrochloride; sodium acetate In methanol at 25℃; for 2h;

2,5-dimethoxy-4-methylbenzaldehyde (4925-88-6) + 2',5'-dimethoxyacetophenone (1201-38-3) → 3-(2',5'-dimethoxy-4-methylphenyl)-1-(2,5-dimethoxyphenyl)-2-propenone

Conditions	Yield
With sodium hydroxide In methanol for 5h; Heating;	91%

2,5-dimethoxy-4-methylbenzaldehyde (4925-88-6) → 2,5-dimethoxy-4-methylphenylmethanol (32176-96-8)

Conditions	Yield
With sodium hydroxide; sodium tetrahydroborate In tetrahydrofuran; water for 0.5h; Ambient temperature;	85%
With sodium hydroxide; sodium tetrahydroborate; water In tetrahydrofuran at 20℃; for 0.5h; Reduction;

2,5-dimethoxy-4-methylbenzaldehyde (4925-88-6) + cyclopropyldiphenylsulfonium tetrafluoroborate (33462-81-6) → 2-(2,5-dimethoxy-4-methylphenyl)cyclobutanone (90791-16-5)

Conditions	Yield
With potassium tert-butylate In tetrahydrofuran at 0℃; for 2h;	84%

2,5-dimethoxy-4-methylbenzaldehyde (4925-88-6) + aniline (62-53-3) → (E)-2,5-dimethoxy-4-methyl-N-phenylbenzaldimin

Conditions	Yield
	84%

cycl-isopropylidene malonate (2033-24-1) + 2,5-dimethoxy-4-methylbenzaldehyde (4925-88-6) → 5-(2,5-Dimethoxy-4-methyl-benzylidene)-2,2-dimethyl-[1,3]dioxane-4,6-dione (117646-12-5)

Conditions	Yield
In N,N-dimethyl-formamide for 12h; Ambient temperature;	83%

2,5-dimethoxy-4-methylbenzaldehyde (4925-88-6) + 4,6-dinitro-m-xylene (616-72-8) → (E,E)-1,3-bis(2,5-dimethoxy-4-methylstyryl)-4,6-dinitrobenzene

Conditions	Yield
With piperidine for 0.15h; microwave irradiation;	82%

2,5-dimethoxy-4-methylbenzaldehyde (4925-88-6) + allylmagnesium bromide (1730-25-2) → 1-(2,5-dimethoxy-4-methylphenyl)but-3-en-1-ol (1254593-04-8)

Conditions	Yield
Stage #1: 2,5-dimethoxy-4-methylbenzaldehyde; allylmagnesium bromide In diethyl ether for 2.5h; Stage #2: With water; ammonium chloride In diethyl ether	81%

2,5-dimethoxy-4-methylbenzaldehyde (4925-88-6) + vinylmagnesium chloride (3536-96-7) → 1-(2,5-dimethoxy-4-methylphenyl)prop-2-en-1-ol

Conditions	Yield
In tetrahydrofuran at 0℃; for 1.5h;	81%

2,5-dimethoxy-4-methylbenzaldehyde (4925-88-6) + methyl (triphenylphosphoranylidene)acetate (21204-67-1) → C13H16O4

Conditions	Yield
In benzene for 4h; Wittig-Horner olefination; Reflux;	80%

2,5-dimethoxy-4-methylbenzaldehyde (4925-88-6) + cyclopropyldiphenylsulfonium triflate (116808-70-9) → 2-(2,5-dimethoxy-4-methylphenyl)cyclobutanone (90791-16-5)

Conditions	Yield
Stage #1: 2,5-dimethoxy-4-methylbenzaldehyde; cyclopropyldiphenylsulfonium triflate With potassium tert-butylate In tetrahydrofuran at -15 - 20℃; for 3h; Stage #2: With tetrafluoroboric acid In tetrahydrofuran at 20℃; for 3h;	80%

2,5-dimethoxy-4-methylbenzaldehyde (4925-88-6) → 1,4-dimethoxy-2-methyl-5-nitrobenzene (32185-64-1) + 3,6-dimethoxy-4-methyl-2-nitrobenzaldehyde

Conditions	Yield
With nitric acid In dichloromethane at 20℃; for 24h;	A 80% B 5%

Nitroethane (79-24-3) + 2,5-dimethoxy-4-methylbenzaldehyde (4925-88-6) → 1-(2,5-Dimethoxy-4-methyl-phenyl)-2-nitro-1-propan (143823-25-0) + 2,5-dimethoxy-4-methyl-benzonitrile (51267-09-5)

Conditions	Yield
With ammonium acetate In acetic acid at 50℃; under 7500600 Torr; for 3h;	A 78% B n/a

2,5-dimethoxy-4-methylbenzaldehyde (4925-88-6) + 1-Nitropropane (108-03-2) → 1,4-Dimethoxy-2-methyl-5-((E)-2-nitro-but-1-enyl)-benzene (134573-08-3) + 2,5-dimethoxy-4-methyl-benzonitrile (51267-09-5)

Conditions	Yield
With ammonium acetate In acetic acid at 50℃; under 7500600 Torr; for 3h;	A 74% B n/a

2,5-dimethoxy-4-methylbenzaldehyde (4925-88-6) + 1-Nitropropane (108-03-2) → 1-(2,5-dimethoxy-4-methylphenyl)-2-nitro-1-butene

Conditions	Yield
With ammonium acetate for 20h; Heating;	72%

2,5-dimethoxy-4-methylbenzaldehyde (4925-88-6) → 4-methyl-2,5-dimethoxy-benzoic acid (32176-94-6)

Conditions	Yield
With potassium permanganate In water at 75℃; for 2h;	71%
Stage #1: 2,5-dimethoxy-4-methylbenzaldehyde With potassium permanganate In water at 75℃; for 2h; Stage #2: With sodium hydroxide In water pH=10;	71%
With dihydrogen peroxide; potassium hydroxide In water at 65℃; for 24.3333h;	70%
With potassium permanganate
With sodium chlorite; aminosulfonic acid In water; acetone for 1.5h; Cooling with ice;	6.36 g

2,5-dimethoxy-4-methylbenzaldehyde (4925-88-6) + 2-(2-iodophenyl)acetonitrile (40400-15-5) → 2-(2,5-dimethoxy-4-methylphenyl)benzofuran-3-carbonitrile

Conditions	Yield
With copper(l) iodide; 4,7-Dimethyl-1,10-phenanthroline; caesium carbonate In dimethyl sulfoxide at 90℃; for 36h; regioselective reaction;	70%

2,5-dimethoxy-4-methylbenzaldehyde (4925-88-6) + Dimethyl succinate (106-65-0) → (E)-3-methoxycarbonyl-4-(2,5-dimethoxy-4-methylphenyl)but-3-enoic acid (97944-74-6)

Conditions	Yield
With potassium tert-butylate In tert-butyl alcohol for 13.5h; Heating;	62%

2,5-dimethoxy-4-methylbenzaldehyde (4925-88-6) + 2-bromoaniline (615-36-1) + 3-(2-nitroethenyl)-1H-indole (3156-51-2) → 8-bromo-2-(2,5-dimethoxy-4-methylphenyl)-4-(1H-indol-3-yl)-3-nitro-1,2,3,4-tetrahydroquinoline

Conditions	Yield
Stage #1: 2,5-dimethoxy-4-methylbenzaldehyde; 2-bromoaniline With iron(III) chloride In 1,2-dichloro-ethane for 0.166667h; Reflux; Stage #2: 3-(2-nitroethenyl)-1H-indole In 1,2-dichloro-ethane for 56h; Reflux;	43%

2,5-dimethoxy-4-methylbenzaldehyde (4925-88-6) → (E)-1,2-bis(2,5-dimethoxy-p-tolyl)ethene (21071-42-1)

Conditions	Yield
With titanium(III) chloride; lithium In 1,2-dimethoxyethane for 16h; Heating;	34%

Nitroethane (79-24-3) + 2,5-dimethoxy-4-methylbenzaldehyde (4925-88-6) → 1-(2,5-Dimethoxy-4-methyl-phenyl)-2-nitro-1-propan (143823-25-0)

nitromethane (75-52-5) + 2,5-dimethoxy-4-methylbenzaldehyde (4925-88-6) → 2,5-Dimethoxy-4-methyl-β-nitrostyrol (25505-64-0)

2,5-dimethoxy-4-methylbenzaldehyde (4925-88-6) + N-acetylglycine (543-24-8) → 4-(2,5-dimethoxy-4-methyl-benzylidene)-2-methyl-4H-oxazol-5-one (35264-88-1)

Conditions	Yield
With sodium acetate In acetic anhydride Heating;

Upstream product

• 4885-02-3 Dichloromethyl methyl ether 
• 24599-58-4 2,5-dimethoxy toluene 
• 557-21-1 dicyanozinc 
• 32176-96-8 2,5-dimethoxy-4-methylphenylmethanol 
• 93-61-8 N-methyl-N-phenylformamide 
• 68-12-2 N,N-dimethyl-formamide 
• 246543-82-8 2-(2,5-dimethoxy-4-methyl-phenyl)-[1,3]dioxolane 
• 95-71-6 2-methylbenzene-1,4-diol 
• 52010-89-6 2,5-dihydroxy-4-methylbenzaldehyde 
• 74-88-4 methyl iodide 

Downstream Products

• 143823-25-0 1-(2,5-Dimethoxy-4-methyl-phenyl)-2-nitro-1-propan 
• 25505-64-0 2,5-Dimethoxy-4-methyl-β-nitrostyrol 
• 117646-12-5 5-(2,5-Dimethoxy-4-methyl-benzylidene)-2,2-dimethyl-[1,3]dioxane-4,6-dione 
• 29907-72-0 1-(2,5-Dimethoxy-4-methyl-phenyl)-2-nitro-propen 
• 51267-09-5 2,5-dimethoxy-4-methyl-benzonitrile 
• 25505-64-0 1-(2,5-dimethoxy-4-methylphenyl)-2-nitroethene 
• 81129-26-2 (Z)-1,4-dimethoxy-2-methyl-5-(prop-1-en-1-yl)benzene 
• 81129-27-3 (E)-1,4-dimethoxy-2-methyl-5-(prop-1-en-1-yl)benzene 
• 90791-16-5 2-(2,5-dimethoxy-4-methylphenyl)cyclobutanone 
• 87050-71-3 4,4'-Dimethyl-2,2',5,5'-tetramethoxy-stilben 
• 21071-42-1 (E)-1,2-bis(2,5-dimethoxy-p-tolyl)ethene 
• 32176-96-8 2,5-dimethoxy-4-methylphenylmethanol 
• 32185-64-1 1,4-dimethoxy-2-methyl-5-nitrobenzene 
• 74516-54-4 2-hydroxy-4-methyl-5-methoxybenzaldehyde 

Relevant academic research and scientific papers

Seven-membered ring compound and application thereof in prevention and treatment of diabetes and metabolic syndrome

The invention discloses a seven-membered ring compound and application thereof in prevention and treatment of diabetes and metabolic syndrome. The structure of the seven-membered ring compound is as shown in a general formula I, and definitions of substituent groups are as shown in the specification and claims. The seven-membered ring compound of the invention has an extremely excellent effect ofpreventing or treating diabetes and metabolic syndrome.

Synthesis of Novel Diaziridinyl Quinone Isoxazole Hybrids and Evaluation of Their Anti-Cancer Activity as Potential Tubulin-Targeting Agents

Two series of diaziridinyl quinone isoxazole derivatives were prepared and evaluated for their cytotoxic activity against MCF7, HeLa, BT549, A549 and HEK293 cell lines and interaction with tubulin. Compounds (6a-m) showed promising activity against all the 5 human cancer cell lines. Compounds 6a, 6e and 6 m were potent [IC 50 ranging between 2.21 μg to 2.87 μg] on ER-positive MCF7 cell line similar to the commercially available drug molecule Doxorubicin. The results from docking models are in consistent with the experimental values which demonstrated the favourable binding modes of compounds 6a-m to the interface of α- and β-tubulin dimer.

LIPIDS AND LIPID COMPOSITIONS FOR THE DELIVERY OF ACTIVE AGENTS

This invention provides for a compound of formula (I), or a pharmaceutically acceptable salt thereof, wherein RA, RB, R2 and R4 are defined herein. The compounds of formula (I) and pharmaceutically acceptable salts thereof are cationic lipids useful in the delivery of biologically active agents to cells and tissues.

Total synthesis of natural enantiomers of heliespirones A and C via the diastereoselective intramolecular Hosomi-Sakurai reaction

A full account of the development of a novel type of the intramolecular Hosomi-Sakurai reactions of the substrates with a pbenzoquinone and an allylsilane moieties connected by an ether linkage is described. This transformation proceeds via an addition-elimination sequence and provides the products with two stereogenic centers through a 1,3(or 1,4)-asymmetric induction in good to excellent diastereoselectivities. A reasonable mechanistic possibility for the reaction, determination of the stereochemistry for the product, and scope and limitation of the transformation are also discussed. The methodology developed here can successfully be applied to the enantiocontrolled total synthesis of the natural enantiomers of (-)-heliespirone A and (+)-heliespirone C, which have been isolated from sunflower Helianthus annuus L. as allelochemicals.

Synthesis of novel isoxazole-benzoquinone hybrids via 1,3-dipolar cycloaddition reaction as key step

An efficient method for the preparation of novel 2-(5-arylisoxazol-3-yl) cyclohexa-2,5-diene-1,4-dione hybrids via 1,3-dipolar cycloaddition followed by an oxidation reaction using ceric ammonium nitrate (CAN) has been described. Using this method, various aryl as well as alkyl substituted isoxazole-benzoquinone hybrids were synthesized in high yields.

Total synthesis of the fungal metabolite (±)-acremine G: Acceleration of a biomimetic Diels-Alder reaction on silica gel

A total synthesis of the bioactive tetracyclic natural product acremine G has been achieved in which a regio- and stereoselective biomimetic Diels-Alder reaction between two readily assembled building blocks, accelerated on a solid support (silica gel), forms the key step.

BENZOFURAN AND BENZOTHIOPHENE-2-CARBOXYLIC ACID AMIDE DERIVATIVES

The present invention relates to compounds of formula I wherein X, A and R1 to R4 are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prevention of diseases which are associated with the modulation of H3 receptors.

Novel triazole derivatives, process for their preparation and pharmaceutical compositions containing them

The invention relates to a compound of formula in which R1, X1, X2, X3, X4, R4, Y1, Y2 and Y3 are as defined in claim 1. These compounds are CCK-receptor agonists.

Triazole derivatives and pharmaceutical compositions comprising them

The present invention relates to compounds of formula (I) and their pharmaccutically acceptable salts, solvates, hydrates and polymorphs. These compounds are powerful and selective CCK1 receptor agonists.

Synthesis of quinones from hydroquinone dimethyl ethers. Oxidative demethylation with cobalt(III) fluoride

The oxidative demethylation of 1,4-dimethoxynaphthalene and 1,4- dimethoxybenzene derivatives with cobalt(III) fluoride proceeded in good to excellent yield to afford the corresponding naphthoquinone and benzoquinone derivatives.